These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Bevacizumab in treating the cystic components of pediatric low-grade gliomas: A report of four patients.
    Author: Levenbaum E, Ellika S, Korones DN.
    Journal: Pediatr Blood Cancer; 2019 Nov; 66(11):e27917. PubMed ID: 31347764.
    Abstract:
    Low-grade gliomas (LGG) are among the most common types of brain tumors in children and young adults. These tumors often consist of solid and cystic components. Bevacizumab is a documented treatment for progressive LGG, yet the impact of therapy on the cystic component of these tumors is unknown. We present four patients with prominently cystic LGG treated with bevacizumab at the time of progression. In each case, the cystic component responded to treatment. This is the first known study to investigate bevacizumab's impact on the cystic component of low-grade gliomas.
    [Abstract] [Full Text] [Related] [New Search]